Abstract
Approximately 40,000 people are diagnosed with rectal cancer in the United States each year. Colonoscopy is the gold standard for colorectal cancer detection. While screening and early detection can prevent the incidence of cancer (by detection in its premalignant state) or allow for disease to be treated at an earlier stage, it remains a leading cause of cancer-related death and carries a worse prognosis compared to colon in terms of local recurrence and overall survival. The management of rectal cancer is distinct from colon cancer in that pre-treatment staging is critical in not only to prognosis, but establishing the treatment algorithm which may consist of local excision, neoadjuvant chemoradiation and/or radical surgery.
| Original language | English |
|---|---|
| Title of host publication | Gastrointestinal Cancers |
| Subtitle of host publication | Prevention, Detection and Treatment |
| Pages | 221-256 |
| Number of pages | 36 |
| Volume | 1 |
| ISBN (Electronic) | 9781536101782 |
| State | Published - Jan 1 2016 |
Bibliographical note
Publisher Copyright:© 2017 Nova Science Publishers, Inc.
ASJC Scopus subject areas
- General Medicine
